Carlsmed (CARL) Total Current Liabilities (2024 - 2026)

Carlsmed (CARL) has reported Total Current Liabilities for 3 consecutive years, with $12.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 30.71% year-over-year to $12.4 million; the trailing twelve-month figure through Jun 2026 stood at $12.4 million (up 30.71% YoY), and the FY2025 full-year result was $14.3 million, up 61.94% from the prior year.
• Total Current Liabilities climbed to $12.4 million in Q2 2026 per CARL's latest filing, from $9.7 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $14.3 million in Q4 2025 and bottomed at $8.8 million in Q4 2024.
• Historically, Total Current Liabilities has averaged $10.9 million across 3 years, with a median of $10.3 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities soared 61.94% in 2025, then jumped 30.71% in 2026.
• Over 3 years, Total Current Liabilities stood at $8.8 million in 2024, then jumped by 61.94% to $14.3 million in 2025, then decreased by 13.19% to $12.4 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $12.4 million, $9.7 million, and $14.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.